This article addresses issues related to the characterization of endocrine-related health effects resulting from low-level exposures to polychlorinated biphenyls (PCBs). It is not intended to be a comprehensive review of the literature but reflects workshop discussions. "The Characterizing the Effects of Endocrine Disruptors on Human Health at Environmental Exposure Levels," workshop provided a forum to discuss the methods and data needed to improve risk assessments of endocrine disruptors. This article contains an overview of endocrine-related (estrogen and thyroid system) interactions and other low-dose effects of PCBs. The data set on endocrine effects includes results obtained from mechanistic methods/ and models (receptor based, metabolism based, and transport protein based), as well as from in vivo models, including studies with experimental animals and wildlife species. Other low-dose effects induced by PCBs, such as neurodevelopmental and reproductive effects and endocrine-sensitive tumors, have been evaluated with respect to a possible causative linkage with PCB-induced alterations in endocrine systems. In addition, studies of low-dose exposure and effects in human populations are presented and critically evaluated. A list of conclusions and recommendations is included.
http.//ehpnetl.niehs.nih.gov/docs/1999/suppl-4/639-649brouwer/abstract.html A National Institute of Environmental Health Sciences' workshop, "Characterizing the Effects of Endocrine Disruptors on Human Health at Environmental Exposure Levels," was held in Raleigh, North Carolina, on 11-13 May 1998 . This workshop was to provide a forum for the discussion on methods and data needed to improve risk assessments of endocrine disruptors. The discussions presented in this paper address the persistent and toxic environmental pollutants polychlorinated biphenyls (PCBs) .
PCBs cause a wide range of effects in experimental animals, wildlife, and humans (1, 2) . This article addresses toxic effects from low-level exposures to PCBs that may be related to endocrine-associated influences on health. The assigned task was a challenge, in part because a) PCBs are a complex mixture that comprise theoretically 209 congeners; b) the toxicity of PCBs is highly dependent on the number and position of chlorine atoms on the biphenyl rings; c) both parent PCBs and their metabolites can cause toxic effects, with the metabolites being mainly associated with endocrine-associated effects; and d) there is a large species difference in toxic effects of PCBs. We also recognize that humans are exposed to high levels of natural compounds in foods that may alter the endocrine activity, if any, of PCBs in humans. Nevertheless, much progress has been made through the study of specific PCB congeners and their metabolic products, which enables an evaluation of potential endocrine-associated adverse health effects of PCBs.
This article is not intended to be a comprehensive review of the literature but reflects workshop discussions. Only data available from peer-reviewed articles were considered for discussion. The following questions were addressed: * What data and models are needed to estimate human risk? * What is the spectrum of observed effects? * What is the quality of the human exposure data?
* What has been the utility of specific animal and in vitro models?
The questions and discussions of these issues are addressed in the same order, with appropriate citations of relevant data. Conclusions and recommendations are given at the end of this article.
What Data and Models Are Needed to Estimate Human Risk?
In principle, the strategy to estimate human risk at low-dose exposure to endocrine disrupting chemicals does not differ from that used for other categories of toxic compounds in the sense that one needs exposure-effect relationships and doseresponse data in experimental animals; in the case of a suggested problem one may rely on wildlife data or human epidemiologic data to support or reject claims of exposure-related adverse health effects. The complexity arises, however, when considering the vast number of different cells, tissues, and organs that could possibly be affected when the supportive endocrine system(s) are disrupted. Consequently, many different exposure-effect relationships may have to be studied to evaluate the full spectrum of adverse effects that could arise following endocrine disruption.
The complexity increases further when considering that most essential physiologic functions such as reproduction and behavior, as well as the processes involved in fetal development, are supported by multiple endocrine systems that may communicate (cross-talk) with each other. Hence, even when a chemical affects a physiologic end point such as reproduction or behavior, it may be difficult to prove that this effect results from disruption of an endocrine system. Finally, endocrine systems can be affected in various ways, e.g., at the receptor level, the various metabolic steps, the organ, processes of synthesis and/or release, the transport systems, and various steps of feedback regulation. This complicates the development of suitable and unequivocal mechanismbased (pre)screening and testing methods to predict potential low-dose health risks from exposure to putative endocrine-disrupting chemical compounds or mixtures.
Although it is difficult to answer the question, What data and models are needed to estimate human risk? based on data and experiences from studies on the effects of PCBs, the PCB database can provide valuable insight on how to evaluate human health risks at environmental exposure levels.
In this article, a concise overview is given of the available data with regard to endocrine-related effects of PCBs, including the full spectrum of low-dose effects observed in animals and effects in humans following accidental or occupational exposure to PCBs. An attempt is made to delineate which of those low-dose end points are to be considered as causally linked to endocrine disruption. The (3) , the thyroid hormone system (4), retinoid system, corticosteroid system and several other endocrine pathways. In addition, the dioxinlike non-ortho and mono-ortho PCBs that exert their effects mainly through the arylhydrocarbon receptor (AhR) pathway may also affect a number of other pathways through cross-talk of the AhR and AhR nuclear transport protein (ARNT) transcription factors with other members of the Per-Arnt-Sim family of helix-loop-helix proteins (5) . The work group agreed to focus their attention on interactions of PCBs with the thyroid and estrogen hormonal systems. The effects observed by PCBs are subdivided into a) endocrine effects on components of the endocrine system such as hormones, metabolic enzymes, carrier proteins, receptors, endocrine glands, and feedback regulation systems, and b) effects that may be associated with changes in endocrine systems: neurodevelopment, reproduction, immune effects, and induction of endocrine-sensitive tumors.
Mechanism-Based Models for Endocrine Effects
Mechanism-based models that are used to study endocrine effects focus on certain aspects of the endocrine system. The in vitro models and methods are particularly suitable to study certain aspects of endocrine systems in isolation. These mechanism-based models may be quite useful as (pre)screening tools to identify putative endocrine-disruptive chemicals and may allow the analysis of large numbers of compounds in short periods of time.
Receptor-based methods and models. These methods and models indude receptorbinding assays, receptor-mediated reporter gene assays, and hormone-dependent cell proliferation assays.
ESTROGEN RECEPTOR-MEDIATED EFFECTS
OF PCBs. Several hydroxylated (OH)-PCBs show binding affinity for the estrogen receptor in in vitro receptor-binding assays (6) (7) (8) .
The most potent congener among the limited set of hydroxy-PCBs tested was 2,4,6,2',6'-pentachloro-4-biphenylol, which was about 5 times less potent than 17p-estradiol (7), although most compounds show much less potency (6, 8) . A number of OHPCBs identified in human serum exhibited antiestrogenic activity in the rat uterine estrogen-binding assay and in the MCF-7 cell proliferation assay (9) . OH-PCBs bound to the estrogen receptor and transactivated the estrogen receptor to DNA binding and altered gene expression in in vitro reporter gene assays (9, 10 (17) . PCB mixtures are also capable of inducing T4 glucuronidation (18) (19) (20) (21) . A negative correlation between plasma T4 levels and hepatic T4 UGT activity has been observed (17) . PCBs also affect thyroid hormone ID enzymes as well as SULT isozymes. Exposure of rats to 3,3',4,4'-tetraCB (PCB 77) resulted in an inhibition of hepatic ID-1 that converts T4 into T3 (triiodothyronine) as well as reverse T3 activity (13, 22) . OH-PCB metabolites competitively inhibited ID-1 activity in isolated rat microsomes (22, 23) . On the other hand, brain ID-2 (converts T4 into T3 exclusively) was enhanced in fetal and neonatal rats born from dams exposed to 3,3',4,4',5,5'-hexaCB (PCB 169) and 3,3',4,4'-tetraCB (PCB 77) (14) . OH-PCBs were also potent inhibitors of thyroid hormone sulfation, competitively inhibiting the SULT enzyme involved (24, 25 (36) .
Effects at lower doses were observed in experiments involving perinatal exposure protocols. For example, severely depressed T4 levels (by 60-90%) were observed in fetal and neonatal rats following in utero exposure to 5 or 25 mg of Aroclor 1254/kg from gestation day 10 to gestation day 16 (32) , while much higher doses of Aroclor 1254 were needed in adult rats to cause similar changes in plasma T4 levels (36) . At postnatal day 21, there were no observable reductions in plasma T4 levels, indicating that perinatal exposure to PCBs did not cause permanent alterations in thyroid hormone levels in the offspring. Reduced plasma T4 levels were also observed in rat pups born to dams exposed to 4 or 16 mg of 2,3',4,4',5-pentaCB (PCB 118) and 16 or 64 mg of 2,2',4,4',5,5'-hexaCB (PCB 153)/kg/day from gestation day 10 to gestation day 16 (41) .
Effects of PCB exposure on thyroid hormone feedback regulation, as measured by thyroid-stimulating hormone (TSH) levels, are equivocal. Some reports indicate an increased TSH concomitant with a low T4 level in adult rats after exposure to PCBs (19, 42, 43) ; other reports, mainly from in utero exposure to PCBs, have not observed an effect on TSH despite severely depressed T4 levels (32) . Reduced brain T4 levels (by 90%) were also observed in fetal rats following in utero exposure to Aroclor 1254 (32) . However, brain T3 levels were marginally affected because of increased activity of the enzyme ID-2, which bioactivates T4 to the active hormone T3. This indicates that an effective compensatory mechanism is operative in late gestational fetuses that may effectively cope with severely reduced T4 levels in critical target organs such as the brain.
Sustained alterations in peripheral thyroid hormone levels will result in a prolonged activation of the hypothalamicpituitary-thyroid (HPT) axis. Evaluation of thyroid gland morphology may therefore be a good indicator for compounds that interfere in thyroid hormone metabolism. Thyroid gland abnormalities have been reported following adult and in utero exposure to Aroclor 1254 in rats and adult exposure in cynomolgus monkeys (44) (45) (46) (47) (48) (49) . The ultrastructural lesions observed in rat thyroid follicular cells after PCB exposure were suggestive of an effect on thyroid hormone synthesis and secretion (47, 50) . However, these thyroid ultrastructural changes were also interpreted as a sustained thyroid activation through the HPT axis (41, 51) .
ESTROGEN SYSTEM EFFECTS. Decreases in serum estradiol and progesterone were reported in rhesus monkeys exhibiting reproductive dysfunction, following exposure to 2,3,7,8-TCDD (500 ppt in the diet for 7 months) (52) and polybrominated biphenyls (53) . Exposure to Aroclor 1248 at doses of 2.5 and 5.0 ppm in the diet caused prolonged menstrual cycles and decreased peak progesterone levels in female rhesus monkeys (54) . Aroclor 1242 caused an increase in basal leutinizing hormone and follicle-stimulating hormone secretion by the pituitary in rats (55 ) .
The uterotropic assay, e.g., an increase in uterine wet weight in prepubertal rats following a short-term exposure (e.g., 4 days) to an estrogenic compound, is frequently used as a functional assay for putative estrogenic compounds. Aroclor mixtures, particularly the lower chlorinated ones including Aroclors 1221, 1232, and 1242, were weakly estrogenic in the uterotropic assay (55) (56) (57) (58) ortho substitution may be related to the weak estrogenic activity of PCB congeners (7, 58 However, studies in wildlife species that are situated at the top of food chains may be quite useful to establish if there are effects at environmentally relevant concentrations.
THYROID HORMONE SYSTEM EFFECTS.
There is a considerable data set for the effects of PCBs on wildlife species. Some studies also provide information on thyroid hormone system effects. Changes in plasma T4 levels were observed in wildlife species exposed either experimentally or environmentally to low doses of PCBs. Harbor seals (Phoca vitulina) held in captivity were exposed for almost 3 years to fish diets that were obtained from a highly polluted area (Baltic Sea) or from a relatively clean area (northeast Atlantic). The diets differed by a factor of 10 in PCB concentrations, and feeding was adjusted for fish protein intake (59) . Seal reproduction was reduced in the group fed the highly polluted fish diet. In plasma samples taken from the seals during the dietary exposure period, significantly reduced total and free thyroxine (TT4, FT4) and total triiodothyronine (TT3) levels were found in the highly polluted fish diet group (60) .
Several studies have been performed on eggs of fish-eating birds that were taken from their nests and artificially hatched in a laboratory incubator. Significant dose-dependent reductions in plasma thyroid hormone concentrations TT4 and FT4 were observed in cormorant hatchlings from high PCBcontaminated breeding colonies compared to those from low PCB-contaminated colonies (61) . The number of hatchlings and fledglings in the high-contaminated breeding colony was significantly reduced compared to that in the low-polluted colony. In addition, 28-day-old eider ducks exposed to 3,3',4,4'-tetraCB (PCB-77) under semifield conditions showed a significant negative correlation between plasma thyroid hormone levels T3 and T4 and liver 3,3',4,4'-tetraCB concentrations (62) Extensive reports have been published on thyroid gland lesions observed in Great Lakes fish species, where a possible linkage with polyhalogenated aromatic hydrocarbon (PHAH) exposure has been suggested (63) . However, other factors such as iodine deficiency or non-PHAH-like waterborne goitrogens may have been involved. Feeding Great Lakes fish diets to rodents resulted in thyroid responses similar to those found in rats exposed to PCBs (64) . Thyroid enlargement was found in several Great Lakes populations of herring gulls sampled between 1974 and 1982 (65) .
ESTROGEN SYSTEM EFFECTS. There is little information on estrogen system effects of PCBs in wildlife species. Adult female mink who were fed diets containing various PCBs 1 month prior to breeding and through parturition developed severe reproductive problems and some changes in sex hormone levels. Aroclor 1254 at 2.5 ppm in the diet caused a decrease in plasma progesterone (66) ; however, 3,3',4,4',5,5'-hexaCB (PCB 169) caused an increase in plasma progesterone. In harbor seals fed fish diets with relatively high levels of PCBs for 2 years, a lower reproductive success was observed; changes in plasma levels of progesterone were also found (59).
Other Low-Dose Effects of PCBs in Experimental Animals That May Be Linked to Endocrine Disruption PCBs induce a wide spectrum of toxic and biochemical effects in experimental animals. In Table 1 , a number of the most important effects are given. In addition, the effects are categorized as low-, moderate-, or high-dose effects and whether there is a suggested link with endocrine disruption.
Endocrine linkage is clear for hormone and endocrine gland-related effects. This is not necessarily the case for the other effects listed in this table. For most of the end points listed in Table 1 , it may be reasonable to suggest a linkage with alterations in an endocrine system; however, this does not indicate that the effect is mediated by an endocrine mechanism.
Neurodevelopmental effects. It is well known that thyroid hormones are very important for normal brain development and that hypothyroidism during fetal and early neonatal life may have profound adverse effects on the developing brain. This may result in reduced axonal and dendritic size and complexity (67) and alterations in the growth and development of a number of different neuronal cell types and glial fibrillary acidic protein (GFAP)-positive astrocytes (68) . In fact, changes in GFAP levels have been observed in several brain regions in postnatal day 90 rat offspring that were exposed in utero and via lactation to Aroclor 1254 (69) . Hypothyroidism also results in changes in the serotonergic and dopaminergic neurotransmitter systems (70) . It is well known that perinatal exposure of rodents to PCB mixtures or to dioxinlike as well as nondioxinlike PCBs causes changes in dopaminergic and serotonergic neurotransmitter concentrations and metabolism (71) (72) (73) . In a perinatal exposure study (74) , similar influences were observed on the serotonergic system by 3,3',4,4'-tetraCB (PCB 77) and the well-known thyroid suppressive agent Environmental Health Perspectives * Vol 07, Supplement 4 * August 999 6-n-propyl-2-thiouracil in rat offspring. Retarded behavioral and cognitive development and profound deafness are consequences of fetal hypothyroidism (75) . Rodent and monkey offspring born to mothers exposed to PCBs perinatally also exhibited learning and behavioral deficits and reduced auditory-evoked potentials at low frequencies (40, (76) (77) (78) (79) (80) . Although quite similar changes in neurodevelopment can be induced by fetal hypothyroidism and by perinatal exposure to PHAHs, this does not necessarily mean that the changes observed by PHAHs are causally linked to alterations in the thyroid hormone system. However, the changes observed in auditory-evoked potentials are more likely linked directly to alterations in the thyroid hormone system (40 (83) . There were also decreases in ventral prostate weight and testicular weight in adult male rats exposed to Aroclor 1254 via lactation. In female rats exposed to Aroclor 1254 via lactation, several adverse effects were observed such as delayed puberty, decreased uterine weight, impaired fertility, and irregular estrus cycles (84 The dioxinlike activity in a sample can be completely characterized by measurements of PCB congeners that include those with the most potent dioxinlike activity (congeners with no ortho position chlorines [coplanar PCBs]) as well as polychlorinated dibenzodioxins (PCDDs; including dioxin itself), and related compounds such as polychlorinated dibenzofurans (PCDFs). These three types of compounds are present at very low concentrations in background-exposed people. Measurement of these very low concentration compounds is expensive and requires relatively large sample volumes. Whether or not these are measured, the total dioxinlike activity of a given sample can be estimated by taking into account the dioxinlike activity of each individual compound and the amount of each compound that is present (95) . The dioxinlike activity of a compound is expressed as a toxic equivalency factor, a multiplier that reflects the compound's dioxinlike potency relative to dioxin (range 0-1). The sum of the concentration of each compound multiplied by its toxic equivalency factor yields a toxic equivalency for the mixture.
Recent studies suggest that among background-exposed people in Europe (96) and North America (97), levels of specific PCB congeners, PCDDs, and PCDFs are highly early-life organochlorine exposure suggest that associations with thyroid function exist and specifically that higher exposure increases TSH. The higher TSH could indicate mild hypothyroidism, which in turn could adversely affect neurodevelopment.
NEURODEVELOPMENT. The results of studies of perinatal PCB or dietary fish exposure in relation to neurodevelopmental outcomes are summarized in Table 3 . The populations studied all had essentially background-level PCB exposure typical of the region, though the range of exposure in Michigan may have been increased somewhat due to frequent fish consumption (104) . Use of fish intake as a surrogate measure of PCB exposure should attenuate associations due to measurement error, and potential confounding of associations with the fish measure by other neurotoxic contaminants of fish, such as methyl mercury, are a concern.`Measured PCBs" in the righthand column of Table 3 refers to measurements in mother's milk, cord blood, maternal serum, etc., which are all highly correlated (96, 105) . The methods of assessing neurodevelopment have been somewhat similar across cohorts. Some parallel findings across cohorts are evident. For example, in the North Carolina and the breast-fed Netherlands subjects, higher PCB exposure was associated with hypotonia at birth and with delayed psychomotor development within 6 months of birth. Furthermore, in both studies the PCB-associated psychomotor delays were no longer evident later in childhood. Findings have not been consistently replicated across studies, however. For example, hypotonia at birth and subsequent delay in psychomotor aspect of the Bayley scales of infant development showed associations with PCB exposure in the Netherlands and North Carolina studies (106) but not in the Michigan study (not shown in Table 3 ). Detrimental effects of PCBs on cognition (IQ, visual recognition memory, and shortterm memory) have been suggested in the Michigan data ( (108) . The possibility of detrimental immunologic effects has also been raised (100) . Epidemiologic associations between adult PCB exposure and health effects.
CANCER. In the study by Loomis et al. (109) on occupational PCB exposure in relation to cancer risk, a dose-response association was found for malignant melanoma. In that study, 88 deaths due to malignant melanoma occurred among exposed workers. Similarly, a meta-analysis including data from all earlier studies of cancer among those occupationally exposed to PCBs (100) also showed an increased risk of skin cancer. That study, in comparison, included only 15 deaths from skin cancer of all types. Previously, the cancers most suspected of being linked to occupational PCB exposure were liver, brain, and malignant melanoma. The results of Loomis et al. (109) and the meta-analysis are inconsistent with one another regarding whether risk is increased for cancer of the liver. At best, both provide weak support for increased risk of brain cancer. Among nonoccupationally exposed women, the relation of PCB blood levels to risk of breast cancer has been examined in a number of large studies (110) (111) (112) (113) . Overall the data do not support an association. In a recent prospective study among subjects with background-level exposure to PCBs, a strong monotonic relation was observed between blood levels of PCBs and subsequent increased risk of non-Hodgkin lymphoma (114) .
OTHER OUTCOMES. Occupational exposure to PCBs has consistently been associated with abnormal liver function tests and chloracne (99) . In men occupationally exposed to PCBs, thyroid hormone level bore no clear relation to measured PCB levels (115 Taiwan (n-1900) and Japan (n -1800) 10 and 20 years after the incident, respectively, was 1.1 in both populations. Deaths from nonmalignant liver disease were increased in both populations. In Japan an excess of deaths from liver cancer was evident (99) . In both populations, the exposed subjects had increased prevalence of chloracne, localized hyperpigmentation, abnormalities of the dermal tissues adjacent to the eye, slowed nerve conduction, abnormalities of a number of laboratory tests on blood, and other symptoms. A group of exposed subjects from Japan had elevated T3 and T4 levels 16 years later (116) .
The Taiwanese children exposed to the mixture in utero were systematically followed and studied. Within 4 years of birth, 21% had died. The children had many of the same manifestations of toxicity as the adults, and in addition had delayed, inhibited growth, permanent intellectual impairment, disordered behavior, more frequent infections, and other problems (117) . Table 4 and quality assurance/quality control information presented for all studies. Details on methods of PCB determination for individual congeners, including recoveries and limits of detection, should be reported. The method of lipid determination and adjustment should be included. For truncated data, the number of samples included in any averaged data set should be stated and the methods used to deal with values below the limit of detection must be explained.
Because the distribution of PCB congeners varies with lipid content, this distribution must be determined in order to apply a lipid adjustment to a particular sample matrix to be used as an indication of body burden.
Ideally, a proficiency program would be established to certij all laboratories performing congener-specific analyses. Proficiency samples would be available for all relevant sample matrices, including serum, plasma, whole blood, milk, fat, and relevant tissues as needed. Proficiency would be demonstrated by participating laboratories on a regular basis. Each matrix would contain the analytes at concentrations normally encountered in population studies. Lipid analysis would be included in the proficiency program.
Vectors of exposure and the resulting levels of PCBs in human populations need to be characterized more fully. There is little data on foods that include meats, fish, fruits and vegetables, processed foods, beverages, etc. The contribution from inhalation exposures, both indoor and outdoor, need to be characterized.
Characterization of congener distributions in human tissues of interest is needed, especially for the OH-and sulfonated PCB metabolites.
Interlaboratory quality control of exposure data should stimulate the interactions and comparability of data from various study cohorts with different background exposure levels to PCBs. This will enhance the quality of estimates of dose-response relationships.
Issues of analytical quality and composition of mixtures for experimental studies should be coordinated by a working group under the auspicies of an international orgamization.
